RELATED PARTY TRANSACTIONS (Tables)

9 Months Ended

Dec. 31, 2019

Table Text Block Supplement [Abstract]

Schedule of Related Party Transactions

The following is a summary of activity between the Group and Pharma, NDM and B&W for the nine months ended December 31, 2019 and 2018, and the year ended March 31, 2019. These amounts are unsecured, interest free, and payable on demand.

	Nine Months Ended December 31, 2019 (unaudited) ($)			Nine Months Ended December 31, 2018 (unaudited) ($)			Year Ended March 31, 2019 ($)
Liability due to related party, beginning of period		964,679			613,818			613,818
Amounts invoiced by DDL to Pharma		(5,874	)		—			(977	)
Amounts invoiced by Pharma to DDL, NM and TCL (1)		1,369,272			1,539,114			2,312,412
Amounts repaid by DDL to Pharma		(1,642,019	)		(1,130,755	)		(1,569,496	)
Amounts invoiced by B&W to DDL		—			—			2,206
Amounts repaid by DDL to B&W		—			—			(5,622	)
Foreign exchange differences		15,970			(103,383	)		(84,843	)
Forgiveness of payable accounted for as an equity contribution		—			—			(302,819	)
Liability due to related party, end of the period		702,028			918,794			964,679

(1) These amounts are included primarily in research and development expenses charged to the Company by Pharma.